For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Pliant Therapeutics Inc (NASDAQ: PLRX) closed at $14.49 in the last session, down -0.21% from day before closing price of $14.52. In other words, the price has decreased by -$0.21 from its previous closing price. On the day, 0.51 million shares were traded. PLRX stock price reached its highest trading level at $15.25 during the session, while it also had its lowest trading level at $14.18.
Ratios:
We take a closer look at PLRX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 14.47 and its Current Ratio is at 14.47. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.15.
Upgrades & Downgrades
On December 08, 2023, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $41.
On May 18, 2023, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $48.Canaccord Genuity initiated its Buy rating on May 18, 2023, with a $48 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jul 10 ’24 when Lefebvre Eric sold 12,319 shares for $11.56 per share. The transaction valued at 142,408 led to the insider holds 213,052 shares of the business.
Hull Hans sold 9,900 shares of PLRX for $114,444 on Jul 10 ’24. The Chief Business Officer now owns 227,494 shares after completing the transaction at $11.56 per share. On Jul 10 ’24, another insider, Cummings Keith Lamont, who serves as the Chief Financial Officer of the company, sold 10,911 shares for $11.56 each. As a result, the insider received 126,131 and left with 282,115 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PLRX now has a Market Capitalization of 881012288 and an Enterprise Value of 504631648.
Stock Price History:
Over the past 52 weeks, PLRX has reached a high of $19.62, while it has fallen to a 52-week low of $10.22. The 50-Day Moving Average of the stock is 12.60%, while the 200-Day Moving Average is calculated to be 6.47%.
Shares Statistics:
According to the various share statistics, PLRX traded on average about 383.60K shares per day over the past 3-months and 366490 shares per day over the past 10 days. A total of 59.92M shares are outstanding, with a floating share count of 53.70M. Insiders hold about 11.68% of the company’s shares, while institutions hold 102.06% stake in the company. Shares short for PLRX as of 1728950400 were 6950795 with a Short Ratio of 18.12, compared to 1726185600 on 7299295. Therefore, it implies a Short% of Shares Outstanding of 6950795 and a Short% of Float of 11.68.
